Search Within

Premal Patel

Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (9)
  2. Genitourinary Oncology Service (9)
  3. Solid Tumor Oncology Division (9)
  4. Body Imaging Service (2)
  5. Radiology, Department of (2)
  6. Biostatistics Service (1)

More Groups

People
  1. Robert Motzer (9)
  2. Gnanamba Kondagunta (3)
  3. Raju Chaganti (3)
  4. Lawrence Schwartz (2)
  5. Nicole Leoce (2)
  6. Rajendrakumar Chadalavada (2)

More People

Years
  1. 2009 (1)
  2. 2008 (3)
  3. 2007 (3)
  4. 2006 (2)
Publications
  1. Journal of Clinical Oncology (3)
  2. American Journal of Hematology/Oncology (1)
  3. British Journal of Cancer (1)
  4. Clinical Cancer Research (1)
  5. Clinical Genitourinary Cancer (1)
  6. EJC Supplements (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Haymarket Media Inc. (1)
  5. Nature Publishing Group (1)
  6. Pergamon-Elsevier Science Ltd (1)

More Publishers

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase i study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma
    Journal Article

    Patel, P. H.; Senico, P. L.; Curiel, R. E.; Motzer, R. J.
    Clinical Genitourinary Cancer (2009)

    Fulltext@MSK | Save
  • Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma
    Meeting Abstract

    Fischer, P.; Patel, P.; Carducci, M. A.; McDermott, D. F.; Hudes, G. R.; Lubiniecki, G. M.; Gelder, M. S.; Senico, P.; Curiel, R. E.; Motzer, R. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Hypoxia-inducible factor (HIF) 1α and 2α levels in cell lines and human tumor predicts response to sunitinib in renal cell carcinoma (RCC)
    Meeting Abstract

    Patel, P. H.; Chadalavada, R. S.; Ishill, N. M.; Patil, S.; Reuter, V. E.; Motzer, R. J.; Chaganti, R. S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma
    Journal Article

    Patel, P. H.; Kondagunta, G. V.; Schwartz, L.; Ishill, N.; Bacik, J.; Deluca, J.; Russo, P.; Motzer, R. J.
    Investigational New Drugs (2008)

    Fulltext@MSK | Save
  • Phase I/II study of sunitinib malate in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Patel, P. H.; Kondagunta, G. V.; Redman, B. G.; Hudes, G. R.; Kim, S. T.; Chen, I.; Motzer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Redman, B. G.; Hudes, G. R.; Kondagunta, G. V.; Patel, P. H.; Kim, S. T.; Chen, I.; Motzer, R. J.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Superior efficacy of sunitinib compared with interferon as first-line therapy in patients with metastatic renal cell carcinoma
    Journal Article

    Patel, P. H.; Schwartz, L. H.; Baum, M. S.; Motzer, R. J.
    American Journal of Hematology/Oncology (2007)

    Fulltext@MSK | Save
  • Targeting von Hippel-Lindau pathway in renal cell carcinoma
    Journal Article

    Patel, P. H.; Chadalavada, R. S. V.; Chaganti, R. S. K.; Motzer, R. J.
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Targeted therapy for metastatic renal cell carcinoma
    Journal Article

    Patel, P. H.; Chaganti, R. S. K.; Motzer, R. J.
    British Journal of Cancer (2006)

    Fulltext@MSK | Save